Tradestie Institutional Equity Comparison Engine
SGHT vs VTAK โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SGHT Overall Edge
SGHT Captures Institutional Edge (3โ0 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sight Sciences, Inc. Common Stock (SGHT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SGHT trades at N/M Forward P/E with -20.2% operating margin (+25.2% YoY revenue) versus VTAK at N/M Forward P/E and -388.1% operating margin (+380.7% YoY). In options structure, SGHT sits in BREAKOUT (8th %ile IV; Dealer Gamma Walls on Pro) against VTAK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SGHT N/M vs VTAK N/M Fwd P/E
Growth & Margin Winner
SGHT
Op Margin -20.2% vs -388.1% ยท YoY +25.2% vs +380.7%
Momentum & Technical Winner
SGHT
1Y +50.2% vs -94.3% ยท 52W Pos 88% vs 1%
Options & Structure Winner
SGHT
BREAKOUT (8th %ile IV) vs UNCLASSIFIED (N/A IV)
SGHT
NASDAQ
Sight Sciences, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$10.59
-2.22% 1D
Market Cap
$601.9M
1M Return
+27.9%
1Y Return
+50.21%
Forward P/E
N/M
Unified AI Score
35.1 / 100
SELL
Tech 50.0
Fund 32.0
Flow 57.0
Mom 50.0
VTAK
NYSE American
Catheter Precision, Inc.
Surgical & Medical Instruments & Apparatus
$0.15
-0.66% 1D
Market Cap
$548,639
1M Return
-24.76%
1Y Return
-94.28%
Forward P/E
N/M
Unified AI Score
58.1 / 100
HOLD
Tech 72.0
Fund 70.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SGHT +50.21%
VTAK -94.28%
Spread: +113.62 pp (SGHT Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SGHT Revenue | VTAK Revenue | SGHT Op. Margin | VTAK Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $10M | N/A | -498.0% | VTAK |
| FY2019 | N/A | $10M | N/A | -801.9% | VTAK |
| FY2020 | $30M | $0M | -116.5% | -13668.3% | SGHT |
| FY2021 | $50M | $0M | -105.2% | -133027.3% | SGHT |
| FY2022 | $70M | $0M | -117.7% | -192578.6% | SGHT |
| FY2023 | $80M | $0M | -70.7% | -17674.0% | SGHT |
| FY2024 | $80M | $0M | -63.3% | -2676.9% | SGHT |
| FY2025 | $80M | $0M | -48.0% | -2581.6% | SGHT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SGHT | VTAK | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $601.9M | $548,639 | Larger Scale | SGHT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +25.2% | +380.7% | Higher Growth | VTAK |
| Operating Margin (TTM) Profitability | -20.2% | -388.1% | Higher Margin | SGHT |
| Net Profit Margin Profitability | -32.1% | 0.0% | Higher Margin | VTAK |
| Return on Equity (ROE) Capital Efficiency | -50.1% | -111.3% | Higher ROE | SGHT |
| 52-Week Range Position Momentum | 88% ($3โ$12) | 1% ($0โ$3) | Stronger Trend | SGHT |
| Beta / 30D Volatility Risk Regime | 1.05ฮฒ ยท 45% Vol | 0.19ฮฒ ยท 76% Vol | Lower Realized Risk | SGHT |
| Unified Institutional Score Composite Signal | 35.1 / 100 (SELL) | 58.1 / 100 (HOLD) | Higher Composite | VTAK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SGHT vs VTAK Buy Guide
SGHT
BREAKOUT
33d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
VTAK
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SGHT nor VTAK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.